Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A comparative analysis of the capacity of the Candida species to elicit vaginal immunopathology.

Willems HME, Lowes DJ, Barker KS, Palmer GE, Peters BM.

Infect Immun. 2018 Sep 24. pii: IAI.00527-18. doi: 10.1128/IAI.00527-18. [Epub ahead of print]

PMID:
30249743
2.

Loss of Upc2p-Inducible ERG3 Transcription Is Sufficient To Confer Niche-Specific Azole Resistance without Compromising Candida albicans Pathogenicity.

Luna-Tapia A, Willems HME, Parker JE, Tournu H, Barker KS, Nishimoto AT, Rogers PD, Kelly SL, Peters BM, Palmer GE.

MBio. 2018 May 22;9(3). pii: e00225-18. doi: 10.1128/mBio.00225-18.

3.

Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa.

Richardson JP, Willems HME, Moyes DL, Shoaie S, Barker KS, Tan SL, Palmer GE, Hube B, Naglik JR, Peters BM.

Infect Immun. 2017 Nov 6. pii: IAI.00645-17. doi: 10.1128/IAI.00645-17. [Epub ahead of print]

4.

Overexpression of Candida albicans Secreted Aspartyl Proteinases 2 or 5 is not sufficient for exacerbation of immunopathology in a murine model of vaginitis.

Willems HME, Bruner WS, Barker KS, Liu J, Palmer GE, Peters BM.

Infect Immun. 2017 Jul 31. pii: IAI.00248-17. doi: 10.1128/IAI.00248-17. [Epub ahead of print]

5.

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.

Rybak JM, Dickens CM, Parker JE, Caudle KE, Manigaba K, Whaley SG, Nishimoto AT, Luna-Tapia A, Roy S, Zhang Q, Barker KS, Palmer GE, Sutter TR, Homayouni R, Wiederhold NP, Kelly SL, Rogers PD.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00651-17. doi: 10.1128/AAC.00651-17. Print 2017 Sep.

6.

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.

Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD.

Front Microbiol. 2017 Jan 12;7:2173. doi: 10.3389/fmicb.2016.02173. eCollection 2016. Review.

7.

The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole.

Whaley SG, Tsao S, Weber S, Zhang Q, Barker KS, Raymond M, Rogers PD.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6060-6. doi: 10.1128/AAC.00732-16. Print 2016 Oct.

8.

Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.

Berkow EL, Manigaba K, Parker JE, Barker KS, Kelly SL, Rogers PD.

Antimicrob Agents Chemother. 2015 Oct;59(10):5942-50. doi: 10.1128/AAC.01358-15. Epub 2015 Jul 13.

9.

Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by Fluconazole.

Vasicek EM, Berkow EL, Bruno VM, Mitchell AP, Wiederhold NP, Barker KS, Rogers PD.

Antimicrob Agents Chemother. 2014 Nov;58(11):6807-18. doi: 10.1128/AAC.00064-14. Epub 2014 Sep 2.

10.

UPC2A is required for high-level azole antifungal resistance in Candida glabrata.

Whaley SG, Caudle KE, Vermitsky JP, Chadwick SG, Toner G, Barker KS, Gygax SE, Rogers PD.

Antimicrob Agents Chemother. 2014 Aug;58(8):4543-54. doi: 10.1128/AAC.02217-13. Epub 2014 May 27.

11.

UPC2 is universally essential for azole antifungal resistance in Candida albicans.

Vasicek EM, Berkow EL, Flowers SA, Barker KS, Rogers PD.

Eukaryot Cell. 2014 Jul;13(7):933-46. doi: 10.1128/EC.00221-13. Epub 2014 Mar 21.

12.

Mitochondrial two-component signaling systems in Candida albicans.

Mavrianos J, Berkow EL, Desai C, Pandey A, Batish M, Rabadi MJ, Barker KS, Pain D, Rogers PD, Eugenin EA, Chauhan N.

Eukaryot Cell. 2013 Jun;12(6):913-22. doi: 10.1128/EC.00048-13. Epub 2013 Apr 12.

13.

Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.

Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD.

Eukaryot Cell. 2012 Oct;11(10):1289-99. doi: 10.1128/EC.00215-12. Epub 2012 Aug 24.

14.

Role of a Candida albicans Nrm1/Whi5 homologue in cell cycle gene expression and DNA replication stress response.

Ofir A, Hofmann K, Weindling E, Gildor T, Barker KS, Rogers PD, Kornitzer D.

Mol Microbiol. 2012 May;84(4):778-94. doi: 10.1111/j.1365-2958.2012.08056.x. Epub 2012 Apr 16.

15.

Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.

Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, Dunkel N, Aïd M, Boucher G, Rogers PD, Raymond M, Morschhäuser J.

Antimicrob Agents Chemother. 2011 May;55(5):2212-23. doi: 10.1128/AAC.01343-10. Epub 2011 Mar 14.

16.

Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon.

Caudle KE, Barker KS, Wiederhold NP, Xu L, Homayouni R, Rogers PD.

Eukaryot Cell. 2011 Mar;10(3):373-83. doi: 10.1128/EC.00073-10. Epub 2010 Dec 30.

17.

Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicans.

Lis M, Liu TT, Barker KS, Rogers PD, Bobek LA.

FEMS Yeast Res. 2010 Aug 1;10(5):579-86. doi: 10.1111/j.1567-1364.2010.00638.x. Epub 2010 May 29.

18.

An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.

Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J.

Antimicrob Agents Chemother. 2010 Jan;54(1):353-9. doi: 10.1128/AAC.01102-09. Epub 2009 Nov 2.

19.

Identification of the Candida albicans Cap1p regulon.

Znaidi S, Barker KS, Weber S, Alarco AM, Liu TT, Boucher G, Rogers PD, Raymond M.

Eukaryot Cell. 2009 Jun;8(6):806-20. doi: 10.1128/EC.00002-09. Epub 2009 Apr 24.

20.

Transcriptome profile of the vascular endothelial cell response to Candida albicans.

Barker KS, Park H, Phan QT, Xu L, Homayouni R, Rogers PD, Filler SG.

J Infect Dis. 2008 Jul 15;198(2):193-202. doi: 10.1086/589516.

PMID:
18500935
21.

A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.

Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD.

Eukaryot Cell. 2008 Jul;7(7):1180-90. doi: 10.1128/EC.00103-08. Epub 2008 May 16.

22.

The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.

Morschhäuser J, Barker KS, Liu TT, BlaB-Warmuth J, Homayouni R, Rogers PD.

PLoS Pathog. 2007 Nov;3(11):e164.

23.

Genome-wide expression and location analyses of the Candida albicans Tac1p regulon.

Liu TT, Znaidi S, Barker KS, Xu L, Homayouni R, Saidane S, Morschhäuser J, Nantel A, Raymond M, Rogers PD.

Eukaryot Cell. 2007 Nov;6(11):2122-38. Epub 2007 Sep 28.

24.

Gene expression profiling of the response of Streptococcus pneumoniae to penicillin.

Rogers PD, Liu TT, Barker KS, Hilliard GM, English BK, Thornton J, Swiatlo E, McDaniel LS.

J Antimicrob Chemother. 2007 Apr;59(4):616-26. Epub 2007 Mar 5.

PMID:
17339278
25.

Recent insights into the mechanisms of antifungal resistance.

Barker KS, Rogers PD.

Curr Infect Dis Rep. 2006 Nov;8(6):449-56.

PMID:
17064638
26.

Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression.

Barker KS, Liu T, Rogers PD.

J Infect Dis. 2005 Sep 1;192(5):901-12. Epub 2005 Jul 20.

PMID:
16088841
27.

Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.

Liu TT, Lee RE, Barker KS, Lee RE, Wei L, Homayouni R, Rogers PD.

Antimicrob Agents Chemother. 2005 Jun;49(6):2226-36.

28.
29.

Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.

Lee RE, Liu TT, Barker KS, Lee RE, Rogers PD.

J Antimicrob Chemother. 2005 May;55(5):655-62. Epub 2005 Apr 6.

PMID:
15814599
30.

Proteomic analysis of azole resistance in Candida albicans clinical isolates.

Hooshdaran MZ, Barker KS, Hilliard GM, Kusch H, Morschhäuser J, Rogers PD.

Antimicrob Agents Chemother. 2004 Jul;48(7):2733-5.

31.

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.

Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD.

J Antimicrob Chemother. 2004 Aug;54(2):376-85. Epub 2004 Jun 16.

PMID:
15201233
32.

Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.

Agarwal AK, Rogers PD, Baerson SR, Jacob MR, Barker KS, Cleary JD, Walker LA, Nagle DG, Clark AM.

J Biol Chem. 2003 Sep 12;278(37):34998-5015. Epub 2003 Jun 24.

33.

Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.

Barker KS, Pearson MM, Rogers PD.

J Antimicrob Chemother. 2003 May;51(5):1131-40. Epub 2003 Apr 14.

PMID:
12697649
34.

Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae.

Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo E, McDaniel LS.

Infect Immun. 2003 Apr;71(4):2087-94.

36.
38.

Channel catfish cytotoxic cells: a mini-review.

Shen L, Stuge TB, Zhou H, Khayat M, Barker KS, Quiniou SM, Wilson M, Bengtén E, Chinchar VG, Clem LW, Miller NW.

Dev Comp Immunol. 2002 Mar;26(2):141-9. Review.

PMID:
11696379
39.

Telomerase expression and telomere length in immortal leukocyte lines from channel catfish.

Barker KS, Quiniou SM, Wilson MR, Bengten E, Stuge TB, Warr GW, Clem LW, Miller NW.

Dev Comp Immunol. 2000 Sep-Oct;24(6-7):583-95.

PMID:
10831793
40.

Development and analysis of various clonal alloantigen-dependent cytotoxic cell lines from channel catfish.

Stuge TB, Wilson MR, Zhou H, Barker KS, Bengtén E, Chinchar G, Miller NW, Clem LW.

J Immunol. 2000 Mar 15;164(6):2971-7.

41.
42.

Supplemental Content

Loading ...
Support Center